
    
      The study was conducted as an open label, balanced, randomised, two-treatment, two-period,
      two-sequence, single-dose, crossover , bioequivalence study on atenolol comparing atenolol
      100mg tablets of Ranbaxy with Tenormin 100mg capsules in healthy, adult, human, subjects
      under fasting conditions.

      A total of 36 non-smoking subjects (26 men and 10 women) were included in this study, of
      which 35 finished the study according to the protocol,
    
  